MICHAEL GREY

Profile

First Name

: MICHAEL

Middle Name

:

Last Name

: GREY

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
AUSPEX PHARMACEUTICALS, INC.
GAURAV AGGARWAL, DAVID COLLIER, ROD FERGUSON, LAWRENCE C. FRITZ, THOMAS GANT, R. GARY GILMORE, RON NEWBOLD, SAM SACHS, SAMUEL SAKS, SEP SARSHAR, SEPEHR SARSHAR, PRATIK SHAH, SEP SHARSHAR, ANDREAS SOMMER, ANDREAS SOMMERS, DAVID STAMLER, DAVID A. STAMLER, DAVID. A. STAMLER
DIRECTOR
ACHILLION PHARMACEUTICALS INC
MILIND S. DESHPANDE, MARY KAY FENTON, JASON S. FISHERMAN, GARY E. FRASHIER, MICHAEL D. KISHBAUCH, DENNIS C. LIOTTA, ELIZABETH OLEK, DAVID I. SCHEER, GAUTAM SHAH, NICHOLAS J. SIMON, JOSEPH TRUITT, ROBERT L. VAN NOSTRAND, DAVID P. WRIGHT
EXECUTIVE OFFICER, DIRECTOR
LUMENA PHARMACEUTICALS, INC.
ROBERT ALEXANDER, ALEJANDRO DORENBAUM, SUSAN E. DUBE, EDWARD E. GREENE, HOWARD E. GREENE, TED GREENE, BRADLEY T. KELLER, CIARA KENNEDY, ROSINA MAAR PAVIA, EDWARD MATHERS, JOHN MCKEARN, JOHN P. MCKEARN, ALANA B. MCNULTY, DAVID R. SAVELLO, FORD S. WORTHY
DIRECTOR
SELVENTA, INC.
NOUBAR AFEYAN, MITCHELL BLOOM, DAVID DE GRAAF, ARNOLD LEVINE, JIM MATHESON, SEAN MCCARTHY, MICHAEL PAVIA, CHRIS THOMAJAN, CHRIS VARMA
DIRECTOR
HORIZON PHARMA, INC.
JEFFREY W. BIRD, HUBERT BIRNER, LOUIS C. BOCK, ROBERT DE VAERE, JEAN-FRANCOIS FORMELA, JEFF HIMAWAN, PETER JOHANN, RONALD PAULI, GINO SANTINI, TIMOTHY P. WALBERT
DIRECTOR
BALANCE THERAPEUTICS, INC.
PETER CARLTON, RICHARD CHIN, LYNDON LIEN, PHYLLIS E. WHITELEY
DIRECTOR, EXECUTIVE OFFICER
AMPLYX PHARMACEUTICALS, INC.
JACK FLORIO, ALAN FUHRMAN, PAUL GRINT, ELAINE HERON, MIKE HODGES, JOHAN K?RDEL, CIARA KENNEDY, JOHAN KORDEL, ED MATHERS, EDWARD MATHERS, ANAND MEHRA, CHRYSA MINEO, MITCHELL MUTZ, NIALL ODONNELL, KAREN TALMADGE, SANTOSH VETTICADEN
EXECUTIVE OFFICER, DIRECTOR
RENEO PHARMACEUTICALS, INC.
SAMUEL AGRESTA, LON CARDON, PH.D., R. MICHAEL CARRUTHERS, MIKE CRUSE, ALEJANDRO DORENBAUM, M.D., GREGORY FLESHER, MICHAEL G. GREY, KENNETH HARRISON, DYLAN HARTLEY, VALERIE M. JANSEN, WENDY JOHNSON, JOHAN KORDEL, PH.D., JASON LEVERONE, ISAAC MANKE, ED MATHERS, EDWARD T. MATHERS, BALI MURALIDHAR, NIALL O-DONNELL, NIALL O-DONNELL, PH.D., ART PAPPAS, ANDREW JOHM PHILLIPS, NICHOLAS SACCOMANO, STACEY SELTZER, SCOTT WEINER
EXECUTIVE OFFICER, DIRECTOR
MIRUM PHARMACEUTICALS, INC.
TIBA AYNECHI, ERIC BJERKHOLT, LAURA BREGE, LON CARDON, IAN CLEMENTS, SUSAN DUBE, WILLIAM C. FAIREY, LAURENT FISCHER, MICHAEL G. GREY, PATRICK HERON, PATRICK J. HERON, JONATHAN LEFF, LARA LONGPRE, ED MATHERS, EDWARD T. MATHERS, NIALL O-DONNELL, CHRIS PEETZ, CHRISTOPHER PEETZ, PETER RADOVICH, SAIRA RAMASASTRY, EDWIN JONATHAN TUCKER, PAMELA VIG, TIMOTHY WALBERT
DIRECTOR, EXECUTIVE OFFICER
SPRUCE BIOSCIENCES, INC.
TIBA AYNECHI, PERCIVAL BARRETTO-KO, SIMPSON CAMILLA, RALPH WILLIAM CHARLTON III, DINA CHAYA, SAMIR GHARIB, JONAS HANSSON, RICHARD KING, BALI MURALIDHAR, NIALL O-DONNELL, CAMILLA SIMPSON, DANIEL SPIEGELMAN, JAVIER SZWARCBERG, KIRK WAYS
DIRECTOR
SORRISO PHARMACEUTICALS, INC.
MARK CHIN, BRIAN DORSEY, SUSAN DUBE, CIARA KENNEDY, PH.D., EDWARD MATHERS
DIRECTOR
PLEXIUM, INC.
LEON CHEN, CARIAD CHESTER, ROB HOPFNER, GORJAN HRUSTANOVIC, MICHAEL MARTIN, SERGE MESSERLIAN, STEPHEN MULLENNIX, PATRICK RIVERS
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-01-29
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2026-01-23 
2025-10-17
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2025-10-09 
2025-08-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-07-14 
2023-02-28
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2023-02-16 
2022-01-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-21 
2020-12-21
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-09 
2020-08-14
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NOT APPLICABLE 
Equity 
2020-02-19 
2020-02-28
D
Link
BIOTECHNOLOGY 
 
NOT APPLICABLE 
Equity 
2020-02-19 
2020-01-09
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-07-14 
2019-05-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-05-01 
2018-11-20
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-05 
2018-01-08
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-12-22 
2017-08-01
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-07-14 
2015-12-24
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-10-29 
2015-11-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-10-29 
2015-05-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-05-06 
2015-05-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-04-24 
2015-03-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-03-05 
2014-03-19
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-03-07 
2013-12-09
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2013-11-22 
2012-05-24
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2011-02-07 
2012-03-19
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-03-02 
2012-03-08
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2012-02-22 
2012-02-08
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2011-02-08 
2011-11-29
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2011-11-16 
2011-06-16
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2011-02-08 
2011-02-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2011-02-08 
2010-08-23
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2010-08-20 
2009-08-03
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2009-05-22